Why am I here?
Gee, willikers, MBD, you haven't been paying attention when I've answered that question a myriad times before.
Here comes the answer yet again. You'd better bookmark it, so you don't need to keep asking it.
I have several hobbies. One of my hobbies is to examine likely candidates for scam stocks. I enjoy the challenge of combing through their SEC filings, looking at their financials using various forensic tools like Benford's law, seeing who's supporting them on MBs
(there's a hard core of posters who post vociferously on such stocks, using a variety of aliases, but clearly the same people. They can never actually post anything positive about the stock they're promoting, just attack those who are more discerning about the stock in question and post positive statements with no logical or empirical arguments)
and predicting their next moves - both the posters and the companies, that is.
The fact that I have had many messages from folk who've read my posts on MBs like those for Viragen, Aptheon, Pharmos, Natural Nano, Pro-Pharmaceuticals, Atlas Mining, Intrepid and Green Energy Resources who've thanked me for encouraging them to do due diligence that's saved them thousands of dollars is merely a pleasant side-effect. The less welcome threats from those who find the First Amendment of the Constitution an unwelcome and dangerous document are less welcome, but also less frequent and will not succeed.
Hope that answers your question.
Now, what was it specifically about the prospects for Biophan that make you so optimistic?
TIA.
BTW, as you probably know, I don't work for a hedge fund. If I did I would have been urging everyone to vote for the MegaDilution.
It has been claimed that the MegaDilution was not approved. If that's so, then let's hope Biophan's manamgement hear what their shareholders were saying to them, rather tha trying to hold the vote yet asgain, and doubtless spending another $50,000 in the process.
After all, that $50K would almost pay a month's worth of interest to the "sewer rats". Shouldn't that be the priority, together with actually advancing the Myotech CSS into clinical studies?
AI
